172 related articles for article (PubMed ID: 16173967)
1. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis.
Wu O; Robertson L; Twaddle S; Lowe G; Clark P; Walker I; Brenkel I; Greaves M; Langhorne P; Regan L; Greer I;
Br J Haematol; 2005 Oct; 131(1):80-90. PubMed ID: 16173967
[TBL] [Abstract][Full Text] [Related]
2. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
3. Is screening for thrombophilia cost-effective?
Wu O; Greer IA
Curr Opin Hematol; 2007 Sep; 14(5):500-3. PubMed ID: 17934357
[TBL] [Abstract][Full Text] [Related]
4. Universal or selected screening for thrombophilia.
Keeling D
Br J Haematol; 2006 Apr; 133(1):106-7. PubMed ID: 16512838
[No Abstract] [Full Text] [Related]
5. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
Mills A; Wilkinson C; Fotherby K
Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
[TBL] [Abstract][Full Text] [Related]
6. Screening for thrombophilia.
Blickstein D
Obstet Gynecol Clin North Am; 2006 Sep; 33(3):389-95. PubMed ID: 16962916
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based indications for thrombophilia screening.
Lindhoff-Last E; Luxembourg B
Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
[TBL] [Abstract][Full Text] [Related]
8. Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective.
O'Brien SH; Smith KJ
J Pediatr; 2009 Jul; 155(1):100-4. PubMed ID: 19324372
[TBL] [Abstract][Full Text] [Related]
9. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
DeSancho MT; Dorff T; Rand JH
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
[TBL] [Abstract][Full Text] [Related]
10. Oral contraception and thrombophilia.
Blickstein D; Blickstein I
Curr Opin Obstet Gynecol; 2007 Aug; 19(4):370-6. PubMed ID: 17625421
[TBL] [Abstract][Full Text] [Related]
11. Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysis.
Smith KJ; Monsef BS; Ragni MV
Thromb Haemost; 2008 Sep; 100(3):447-52. PubMed ID: 18766261
[TBL] [Abstract][Full Text] [Related]
12. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis.
Saadatnia M; Tajmirriahi M
Acta Neurol Scand; 2007 May; 115(5):295-300. PubMed ID: 17489938
[TBL] [Abstract][Full Text] [Related]
13. Who should be tested for thrombophilia?
Simioni P
Curr Opin Hematol; 2006 Sep; 13(5):337-43. PubMed ID: 16888438
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and inherited thrombophilia: a gene-environment interaction with a risk of venous thrombosis?
Mac Gillavry MR; Prins MH
Semin Thromb Hemost; 2003 Apr; 29(2):219-26. PubMed ID: 12709926
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
Kwon JS; Lu KH
Obstet Gynecol; 2008 Jul; 112(1):56-63. PubMed ID: 18591308
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy and thromboembolic disease.
Battaglioli T; Martinelli I
Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
[TBL] [Abstract][Full Text] [Related]
17. Routine antenatal thrombophilia screening in high-risk pregnancies: a decision analysis.
Woodham PC; Boggess KA; Gardner MO; Doyle NM
Am J Perinatol; 2011 Jun; 28(6):495-500. PubMed ID: 21380983
[TBL] [Abstract][Full Text] [Related]
18. Screening for familial intracranial aneurysms: decision and cost-effectiveness analysis.
Takao H; Nojo T; Ohtomo K
Acad Radiol; 2008 Apr; 15(4):462-71. PubMed ID: 18342771
[TBL] [Abstract][Full Text] [Related]
19. [A multicentre randomised clinical trial to evaluate the benefit of testing for thrombophilia following a first venous thromboembolism: the NOSTRADAMUS study].
Cohn DM; Middeldorp S
Ned Tijdschr Geneeskd; 2007 Feb; 151(6):371-3. PubMed ID: 17352304
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate.
Mobley LR; Hoerger TJ; Wittenborn JS; Galuska DA; Rao JK
Med Decis Making; 2006; 26(2):194-206. PubMed ID: 16525173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
